Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Jun;42(4):E7-E8.
doi: 10.1503/jpn.170022.

Recognition and management of antidepressant discontinuation syndrome

Venkat Bhat  1 , Sidney H Kennedy  1
Affiliations
Case Reports

Recognition and management of antidepressant discontinuation syndrome

Venkat Bhat et al. J Psychiatry Neurosci. 2017 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: V. Bhat is supported by the Canadian Biomarker Integration Network for Depression. S. Kennedy reports grants from BMS, Janssen, Lundbeck, Pfizer, Servier, St. Jude Medical, the Ontario Brain Institute, Canadian Institutes of Health Research, Brain Canada, the Ontario Mental Health Foundation and the Ontario Research Fund; is on the advisory boards of and has received personal fees from Allergan, AstraZeneca, BMS, Janssen, Lundbeck, Pfizer, Servier, St. Jude Medical and Sunovion; has received speaker fees from Xian-Janssen; and has received research support from Brain Cells Inc and Clera.

References

    1. American Psychiatric Association. DSM 5. Arlington (Va): APA; 2013.
    1. Fava GA, Gatti A, Belaise C, et al. Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychother Psychosom. 2015;84:72–81. - PubMed
    1. Rosenbaum JF, Fava M, Hoog SL, et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry. 1998;44:77–87. - PubMed
    1. Michelson D, Fava M, Amsterdam J, et al. Interruption of selective serotonin reuptake inhibitor treatment. Br J Psychiatry. 2000;176:363–8. - PubMed
    1. Meijer WE, Bouvy ML, Heerdink ER, et al. Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitors. Br J Psychiatry. 2001;179:519–22. - PubMed

Publication types

MeSH terms

Substances